-
1
-
-
77952243719
-
Lipocalin-2: Pro- or anti-apoptotic?
-
Kehrer JP (2010). Lipocalin-2: pro- or anti-apoptotic? Cell Biol Toxicol, 26:83-9.
-
(2010)
Cell Biol Toxicol
, vol.26
, pp. 83-89
-
-
Kehrer, J.P.1
-
2
-
-
27744448101
-
Lipocalin 2 functions as a negative regulator of red blood cell production in an autocrine fashion
-
Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y (2005). Lipocalin 2 functions as a negative regulator of red blood cell production in an autocrine fashion. FASEB J, 19:1881-3.
-
(2005)
FASEB J
, vol.19
, pp. 1881-1883
-
-
Miharada, K.1
Hiroyama, T.2
Sudo, K.3
Nagasawa, T.4
Nakamura, Y.5
-
3
-
-
47049118231
-
Lipocalin-2: Development, analytical characterization, and clinical testing of a new ELISA
-
Stejskal D, Karpisek M, Humenanska V, Hanulova Z, Stejskal P, Kusnierova P, Petzel M (2008). Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA. Horm Metab Res, 40:381-5.
-
(2008)
Horm Metab Res
, vol.40
, pp. 381-385
-
-
Stejskal, D.1
Karpisek, M.2
Humenanska, V.3
Hanulova, Z.4
Stejskal, P.5
Kusnierova, P.6
Petzel, M.7
-
4
-
-
34948856953
-
The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance
-
Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, Xu Z, Houstis NE, Kahn BB, Rosen ED (2007). The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes, 56:2533-40.
-
(2007)
Diabetes
, vol.56
, pp. 2533-2540
-
-
Yan, Q.W.1
Yang, Q.2
Mody, N.3
Graham, T.E.4
Hsu, C.H.5
Xu, Z.6
Houstis, N.E.7
Kahn, B.B.8
Rosen, E.D.9
-
5
-
-
64549113076
-
Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin
-
Tan BK, Adya R, Shan X, Syed F, Lewandowski KC, O'Hare JP, Randeva HS (2009). Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin. Diabetes Care, 32:129-31.
-
(2009)
Diabetes Care
, vol.32
, pp. 129-131
-
-
Tan, B.K.1
Adya, R.2
Shan, X.3
Syed, F.4
Lewandowski, K.C.5
O'hare, J.P.6
Randeva, H.S.7
-
6
-
-
0029790266
-
The lipocalin protein family: Structure and function
-
Flower DR (1996). The lipocalin protein family: structure and function. Biochem J, 318 (Pt 1):1-14.
-
(1996)
Biochem J
, vol.318
, pp. 1-14
-
-
Flower, D.R.1
-
7
-
-
0033365057
-
Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans
-
Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP (1999). Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet, 64:1127-40.
-
(1999)
Am J Hum Genet
, vol.64
, pp. 1127-1140
-
-
Duggirala, R.1
Blangero, J.2
Almasy, L.3
Dyer, T.D.4
Williams, K.L.5
Leach, R.J.6
O'connell, P.7
Stern, M.P.8
-
8
-
-
0036317628
-
A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study
-
Meigs JB, Panhuysen CI, Myers RH, Wilson PW, Cupples LA (2002). A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes, 51:833-40.
-
(2002)
Diabetes
, vol.51
, pp. 833-840
-
-
Meigs, J.B.1
Panhuysen, C.I.2
Myers, R.H.3
Wilson, P.W.4
Cupples, L.A.5
-
9
-
-
0021112784
-
Cloning and sequencing of a full length cDNA coding for human retinol-binding protein
-
Colantuoni V, Romano V, Bensi G, Santoro C, Costanzo F, Raugei G, Cortese R (1983). Cloning and sequencing of a full length cDNA coding for human retinol-binding protein. Nucleic Acids Res, 11:7769-76.
-
(1983)
Nucleic Acids Res
, vol.11
, pp. 7769-7776
-
-
Colantuoni, V.1
Romano, V.2
Bensi, G.3
Santoro, C.4
Costanzo, F.5
Raugei, G.6
Cortese, R.7
-
10
-
-
0029015954
-
Characterization of two post-translationally processed forms of human serum retinol-binding protein: Altered ratios in chronic renal failure
-
Jaconi S, Rose K, Hughes GJ, Saurat JH, Siegenthaler G (1995). Characterization of two post-translationally processed forms of human serum retinol-binding protein: altered ratios in chronic renal failure. J Lipid Res, 36:1247-53.
-
(1995)
J Lipid Res
, vol.36
, pp. 1247-1253
-
-
Jaconi, S.1
Rose, K.2
Hughes, G.J.3
Saurat, J.H.4
Siegenthaler, G.5
-
11
-
-
58149394428
-
Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women
-
Mallat Z, Simon T, Benessiano J, Clement K, Taleb S, Wareham NJ, Luben R, Khaw KT, Tedgui A, Boekholdt SM (2009). Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. J Clin Endocrinol Metab, 94:255-60.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 255-260
-
-
Mallat, Z.1
Simon, T.2
Benessiano, J.3
Clement, K.4
Taleb, S.5
Wareham, N.J.6
Luben, R.7
Khaw, K.T.8
Tedgui, A.9
Boekholdt, S.M.10
-
12
-
-
77949435819
-
Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction
-
Sasaki M, Otani T, Kawakami M, Ishikawa SE (2010). Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction. Metabolism, 59:527-32.
-
(2010)
Metabolism
, vol.59
, pp. 527-532
-
-
Sasaki, M.1
Otani, T.2
Kawakami, M.3
Ishikawa, S.E.4
-
13
-
-
68949205087
-
Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly
-
Ingelsson E, Sundstrom J, Melhus H, Michaelsson K, Berne C, Vasan RS, Riserus U, Blomhoff R, Lind L, Arnlov J (2009). Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis, 206:239-44.
-
(2009)
Atherosclerosis
, vol.206
, pp. 239-244
-
-
Ingelsson, E.1
Sundstrom, J.2
Melhus, H.3
Michaelsson, K.4
Berne, C.5
Vasan, R.S.6
Riserus, U.7
Blomhoff, R.8
Lind, L.9
Arnlov, J.10
-
14
-
-
35948958565
-
Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor
-
Promintzer M, Krebs M, Todoric J, Luger A, Bischof MG, Nowotny P, Wagner O, Esterbauer H, Anderwald C (2007). Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab, 92:4306-12.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 4306-4312
-
-
Promintzer, M.1
Krebs, M.2
Todoric, J.3
Luger, A.4
Bischof, M.G.5
Nowotny, P.6
Wagner, O.7
Esterbauer, H.8
Anderwald, C.9
-
15
-
-
34447116230
-
Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects
-
Broch M, Vendrell J, Ricart W, Richart C, Fernandez-Real JM (2007). Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care, 30:1802-6.
-
(2007)
Diabetes Care
, vol.30
, pp. 1802-1806
-
-
Broch, M.1
Vendrell, J.2
Ricart, W.3
Richart, C.4
Fernandez-Real, J.M.5
-
16
-
-
33947544987
-
Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects
-
Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B (2007). Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab, 92:1168-71.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 1168-1171
-
-
Haider, D.G.1
Schindler, K.2
Prager, G.3
Bohdjalian, A.4
Luger, A.5
Wolzt, M.6
Ludvik, B.7
-
17
-
-
33745095399
-
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects
-
Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB (2006). Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med, 354:2552-63.
-
(2006)
N Engl J Med
, vol.354
, pp. 2552-2563
-
-
Graham, T.E.1
Yang, Q.2
Bluher, M.3
Hammarstedt, A.4
Ciaraldi, T.P.5
Henry, R.R.6
Wason, C.J.7
Oberbach, A.8
Jansson, P.A.9
Smith, U.10
Kahn, B.B.11
-
18
-
-
22944434929
-
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
-
Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB (2005). Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 436:356-62.
-
(2005)
Nature
, vol.436
, pp. 356-362
-
-
Yang, Q.1
Graham, T.E.2
Mody, N.3
Preitner, F.4
Peroni, O.D.5
Zabolotny, J.M.6
Kotani, K.7
Quadro, L.8
Kahn, B.B.9
-
19
-
-
84866270467
-
Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: A systematic review and meta-analysis
-
Zheng JS, Huang T, Yang J, Fu YQ, Li D (2012). Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS One, 7:e44525.
-
(2012)
Plos One
, vol.7
-
-
Zheng, J.S.1
Huang, T.2
Yang, J.3
Fu, Y.Q.4
Li, D.5
-
20
-
-
84867693554
-
PPARgamma as a molecular target of EPA anti-inflammatory activity during TNF-alpha-impaired skeletal muscle cell differentiation
-
Magee P, Pearson S, Whittingham-Dowd J, Allen J (2012). PPARgamma as a molecular target of EPA anti-inflammatory activity during TNF-alpha-impaired skeletal muscle cell differentiation. J Nutr Biochem, 23:1440-8.
-
(2012)
J Nutr Biochem
, vol.23
, pp. 1440-1448
-
-
Magee, P.1
Pearson, S.2
Whittingham-Dowd, J.3
Allen, J.4
-
21
-
-
20444366199
-
Fatty acids and expression of adipokines
-
Drevon CA (2005). Fatty acids and expression of adipokines. Biochim Biophys Acta, 1740:287-92.
-
(2005)
Biochim Biophys Acta
, vol.1740
, pp. 287-292
-
-
Drevon, C.A.1
-
22
-
-
2342435824
-
Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1
-
Lee JY, Zhao L, Youn HS, Weatherill AR, Tapping R, Feng L, Lee WH, Fitzgerald KA, Hwang DH (2004). Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem, 279:16971-9.
-
(2004)
J Biol Chem
, vol.279
, pp. 16971-16979
-
-
Lee, J.Y.1
Zhao, L.2
Youn, H.S.3
Weatherill, A.R.4
Tapping, R.5
Feng, L.6
Lee, W.H.7
Fitzgerald, K.A.8
Hwang, D.H.9
-
23
-
-
42649089790
-
Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators
-
Serhan CN, Chiang N, Van Dyke TE (2008). Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol, 8:349-61.
-
(2008)
Nat Rev Immunol
, vol.8
, pp. 349-361
-
-
Serhan, C.N.1
Chiang, N.2
Van Dyke, T.E.3
-
24
-
-
80054807703
-
Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: The prospective Cyprus Metabolism Study
-
Liu X, Hamnvik OP, Petrou M, Gong H, Chamberland JP, Christophi CA, Kales SN, Christiani DC, Mantzoros CS (2011). Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism Study. Eur J Endocrinol, 165:805-12.
-
(2011)
Eur J Endocrinol
, vol.165
, pp. 805-812
-
-
Liu, X.1
Hamnvik, O.P.2
Petrou, M.3
Gong, H.4
Chamberland, J.P.5
Christophi, C.A.6
Kales, S.N.7
Christiani, D.C.8
Mantzoros, C.S.9
-
25
-
-
84856363510
-
Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people
-
Huang Y, Yang Z, Ye Z, Li Q, Wen J, Tao X, Chen L, He M, Wang X, Lu B, Zhang Z, Zhang W, Qu S, Hu R (2012). Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people. Cardiovasc Diabetol, 11:11.
-
(2012)
Cardiovasc Diabetol
, vol.11
, pp. 11
-
-
Huang, Y.1
Yang, Z.2
Ye, Z.3
Li, Q.4
Wen, J.5
Tao, X.6
Chen, L.7
He, M.8
Wang, X.9
Lu, B.10
Zhang, Z.11
Zhang, W.12
Qu, S.13
Hu, R.14
-
26
-
-
84857999164
-
Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes
-
Derosa G, Cicero AF, D'Angelo A, Fogari E, Maffioli P (2012). Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes. J Clin Pharm Ther, 37:187-95.
-
(2012)
J Clin Pharm Ther
, vol.37
, pp. 187-195
-
-
Derosa, G.1
Cicero, A.F.2
D'angelo, A.3
Fogari, E.4
Maffioli, P.5
-
27
-
-
79959997617
-
Acarbose on insulin resistance after an oral fat load: A double-blind, placebo controlled study
-
Derosa G, Maffioli P, D'Angelo A, Fogari E, Bianchi L, Cicero AF (2011). Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study. J Diabetes Complications, 25:258-66.
-
(2011)
J Diabetes Complications
, vol.25
, pp. 258-266
-
-
Derosa, G.1
Maffioli, P.2
D'angelo, A.3
Fogari, E.4
Bianchi, L.5
Cicero, A.F.6
-
28
-
-
67649438787
-
Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients
-
Pan A, Demark-Wahnefried W, Ye X, Yu Z, Li H, Qi Q, Sun J, Chen Y, Chen X, Liu Y, Lin X (2009). Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients. Br J Nutr, 101:1145-9.
-
(2009)
Br J Nutr
, vol.101
, pp. 1145-1149
-
-
Pan, A.1
Demark-Wahnefried, W.2
Ye, X.3
Yu, Z.4
Li, H.5
Qi, Q.6
Sun, J.7
Chen, Y.8
Chen, X.9
Liu, Y.10
Lin, X.11
-
29
-
-
34447118227
-
Retinol binding protein-4 levels and clinical features of type 2 diabetes patients
-
Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T (2007). Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab, 92:2712-9.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 2712-2719
-
-
Takebayashi, K.1
Suetsugu, M.2
Wakabayashi, S.3
Aso, Y.4
Inukai, T.5
-
30
-
-
44349107197
-
Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea
-
Lin KD, Chang YH, Wang CL, Yang YH, Hsiao PJ, Li TH, Shin SJ (2008). Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea. Transl Res, 151:309-14.
-
(2008)
Transl Res
, vol.151
, pp. 309-314
-
-
Lin, K.D.1
Chang, Y.H.2
Wang, C.L.3
Yang, Y.H.4
Hsiao, P.J.5
Li, T.H.6
Shin, S.J.7
|